PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
8.27%
Growth of 8.27% versus flat Medical - Pharmaceuticals revenue. Walter Schloss would verify growth quality.
7.56%
Cost growth of 7.56% versus flat Medical - Pharmaceuticals costs. Walter Schloss would verify cost control.
11.47%
Growth of 11.47% versus flat Medical - Pharmaceuticals gross profit. Walter Schloss would verify quality.
2.96%
Margin change of 2.96% versus flat Medical - Pharmaceuticals margins. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.40%
Other expenses change of 26.40% versus flat Medical - Pharmaceuticals costs. Walter Schloss would verify efficiency.
10.30%
Operating expenses growth exceeding 1.5x Medical - Pharmaceuticals median of 2.38%. Jim Chanos would check for waste.
7.96%
Total costs change of 7.96% versus flat Medical - Pharmaceuticals costs. Walter Schloss would verify control.
No Data
No Data available this quarter, please select a different quarter.
23.91%
D&A change of 23.91% versus flat Medical - Pharmaceuticals D&A. Walter Schloss would verify adequacy.
15.01%
EBITDA change of 15.01% versus flat Medical - Pharmaceuticals. Walter Schloss would verify quality.
6.22%
Margin change of 6.22% versus flat Medical - Pharmaceuticals. Walter Schloss would verify quality.
15.53%
Income change of 15.53% versus flat Medical - Pharmaceuticals. Walter Schloss would verify quality.
6.70%
Margin change of 6.70% versus flat Medical - Pharmaceuticals. Walter Schloss would verify quality.
25.33%
Other expenses change of 25.33% versus flat Medical - Pharmaceuticals. Walter Schloss would verify control.
16.16%
Income change of 16.16% versus flat Medical - Pharmaceuticals. Walter Schloss would verify quality.
7.28%
Margin change of 7.28% versus flat Medical - Pharmaceuticals. Walter Schloss would verify quality.
20.73%
Tax expense change of 20.73% versus flat Medical - Pharmaceuticals. Walter Schloss would verify strategy.
12.54%
Income change of 12.54% versus flat Medical - Pharmaceuticals. Walter Schloss would verify quality.
3.94%
Margin change of 3.94% versus flat Medical - Pharmaceuticals. Walter Schloss would verify quality.
12.53%
EPS growth exceeding 1.5x Medical - Pharmaceuticals median of 5.00%. Joel Greenblatt would investigate advantages.
12.53%
Diluted EPS growth exceeding 1.5x Medical - Pharmaceuticals median of 5.26%. Joel Greenblatt would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.